| |
property for sale in paphos polis cyprus
News and Information Article
BOHEMIA, N.Y., Sept. 13 /-FirstCall/ -- NBTY, Inc. (NYSE:
NTY) (http://www.NBTY.com), a leading global manufacturer and marketer of
nutritional supplements, today announced that it will web cast the
presentation by Harvey Kamil, President and Chief Financial Officer of
NBTY, at the CL King Best Ideas Conference in New York on Tuesday,
September 19, 2006. The Conference is being held at the Omni Berkshire
Place Hotel.
The presentation is scheduled to be web cast live on NBTYs web site,
(http://www.nbty.com) on Tuesday, September 19, 2006 at 4:00 PM Eastern Time.
NBTYs preliminary unaudited net sales results for August 2006 by
segment are as follows (amounts are rounded):
NET SALES
(Preliminary and Unaudited)
FOR THE MONTH OF AUGUST
($ In Millions)
2006 2005 %Change
Wholesale/US Nutrition $72 $70 3%
North American Retail/
Vitamin World $19 $19 2%
European Retail/
Holland & Barrett/GNC (UK) $49 $46 7%
Direct Response/
Puritans Pride $14 $14 -2%
Total $153 $148 4%
European retail net sales in local currency increased 1% in August 2006.
NBTYs preliminary unaudited sales results for the two months July and
August 2006 by segment are as follows (amounts are rounded):
NET SALES
(Preliminary and Unaudited)
FOR THE TWO MONTHS OF JULY AND AUGUST
($ In Millions)
2006 2005 % Change
Wholesale/US Nutrition $141 $122 15%
North American Retail/
Vitamin World $38 $38 0%
European Retail/
Holland & Barrett/GNC (UK) $94 $91 3%
Direct Response/
Puritans Pride $29 $28 4%
Total $302 $279 8%
The above preliminary unaudited sales results for August 2006 and 2005
included net sales from Solgar, which was acquired in August 2005. The
preliminary unaudited sales results for July 2006 included net sales of $8
million from Solgar. European retail net sales in local currency decreased
2% for the two-month period in 2006.
ABOUT NBTY
NBTY is a leading vertically integrated manufacturer, marketer and
distributor of a broad line of high-quality, value-priced nutritional
supplements in the United States and throughout the world. Under a number
of NBTY and third party brands, the Company offers over 22,000 products,
including products marketed by the Companys Natures Bounty(R), Vitamin
World(R), Puritans Pride(R), Holland & Barrett(R), Rexall(R), Sundown(R),
MET-Rx(R), WORLDWIDE Sport Nutrition(R), American Health(R), GNC (UK)(R),
DeTuinen(R), LeNaturiste(TM), SISU(R) and Solgar(R) brands.
This release contains certain forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995 with
respect to our financial condition, results of operations and business.
These forward-looking statements can be identified by the use of
terminology such as "subject to," "believe," "expects," "plan," "project,"
"estimate," "intend," "may," "will," "should," "can," or "anticipates," or
the negative thereof, or variations thereon, or comparable terminology, or
by discussions of strategy. Although all of these forward-looking
statements are believed to be reasonable, they are inherently uncertain.
Factors which may materially affect such forward-looking statements
include: (i) slow or negative growth in the nutritional supplement
industry; (ii) interruption of business or negative impact on sales and
earnings due to acts of God, acts of war, terrorism, bio- terrorism, civil
unrest or disruption of mail service; (iii) adverse publicity regarding
nutritional supplements; (iv) inability to retain customers of companies
(or mailing lists) recently acquired; (v) increased competition; (vi)
increased costs; (vii) loss or retirement of key members of management;
(viii) increases in the cost of borrowings and/or unavailability of
additional debt or equity capital; (ix) unavailability of, or inability to
consummate, advantageous acquisitions in the future, including those that
may be subject to bankruptcy approval or the inability of NBTY to integrate
acquisitions into the mainstream of its business; (x) changes in general
worldwide economic and political conditions in the markets in which NBTY
may compete from time to time; (xi) the inability of NBTY to gain and/or
hold market share of its wholesale and/or retail customers anywhere in the
world; (xii) unavailability of electricity in certain geographical areas;
(xiii) the inability of NBTY to obtain and/or renew insurance and/or the
costs of the same; (xiv) exposure to and expense of defending and resolving
product liability and intellectual property claims and other litigation;
(xv) the ability of NBTY to successfully implement its business strategy;
(xvi) the inability of NBTY to manage its retail, wholesale, manufacturing
and other operations efficiently; (xvii) consumer acceptance of NBTYs
products; (xviii) the inability of NBTY to renew leases for its retail
locations; (xix) the inability of NBTYs retail stores to attain or
maintain profitability; (xx) the absence of clinical trials for many of
NBTYs products; (xxi) sales and earnings volatility and/or trends for the
Company and its market segments; (xxii) the efficacy of NBTYs Internet and
on-line sales and marketing strategies; (xxiii) fluctuations in foreign
currencies, including the British Pound, the Euro and the Canadian dollar;
(xxiv) import-export controls on sales to foreign countries; (xxv) the
inability of NBTY to secure favorable new sites for, and delays in opening,
new retail locations; (xxvi) introduction of and compliance with new
federal, state, local or foreign legislation or regulation or adverse
determinations by regulators anywhere in the world (including the banning
of products) and more particularly proposed Good Manufacturing Practices in
the United States, the Food Supplements Directive and Traditional Herbal
Medicinal Products Directive in Europe and Section 404 requirements of the
Sarbanes-Oxley Act of 2002; (xxvii) the mix of NBTYs products and the
profit margins thereon; (xxviii) the availability and pricing of raw
materials; (xxix) risk factors discussed in NBTYs filings with the U.S.
Securities and Exchange Commission; (xxx) adverse effects on NBTY as a
result of increased gasoline prices and potentially reduced traffic flow to
NBTYs retail locations; (xxxi) adverse tax determinations; (xxxii) the
loss of a significant customer of the Company; and (xxxiii) other factors
beyond the Companys control.
Readers are cautioned not to place undue reliance on forward-looking
statements. NBTY cannot guarantee future results, trends, events, levels of
activity, performance or achievements. NBTY does not undertake and
specifically declines any obligation to update, republish or revise
forward- looking statements to reflect events or circumstances after the
date hereof or to reflect the occurrences of unanticipated events.
Consequently, such forward-looking statements should be regarded solely
as NBTYs current plans, estimates and beliefs.
Contact: Harvey Kamil Carl Hymans
NBTY, Inc. G.S. Schwartz & Co.
President & Chief Financial Officer 212-725-4500
631-200-2020 carlh@schwartz.com
| |
|
|
 |
property for sale in paphos polis cyprus |
|
|
|
|
|
|
|
|
|
Locations
